Options Brief: Valeant Pharmaceuticals International (VRX)

Shares of Valeant Pharmaceuticals International VRX are lower on the session by 1.12%, trading at $51.31. Overall call volume is now running at 3.40x the daily average, with 1% of all calls traded being purchases on the offer. 24,303 contracts have traded on the session so far. Valeant Pharmaceuticals International, Inc., formerly Biovail Corporation, is a multinational, specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products.